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Administration of 8-methoxypsoralen followed by ultravio-
let A irradiation (PUV A treatment) has been used as a therapy 
for urticaria pigmentosa. The effect of PUVA treatment on 
cutaneous mast cells in mice was investigated by using giant 
granules of mast cells from C57BL/6-bgl jbgl (Chediak-Hi-
gashi syndrome) mice as a marker. C57BL/ 6-+ j+ mice were 
lethally irradiated and rescued by bone marrow transplanta-
tion from C57BL/6-bgl jbgl mice. In the radiation chimeras, 
mast cells in the skin were of+ j+ type and mast-cell precur-
sors migrating in the bloodstream were bgl jbgl. When 
PUV A treatment was applied to the skin of the radia-
M ast cells are normal inhabitants of the skin, bur precursors of mast cells are derived from the bone marrow [1]. Although most of the progeny of hematopoietic stem cells leave the bone marrow only after maturation, undifferentiated precursors 
of mast cells leave the bone marrow, migrate via the bloodstream 
[2-4], and invade the skin. After the invasion, they proliferate and 
differentiate into mast cells [5,6]. Even after their morphologic dif-
ferentiation, an appreciable proportion of mast cells retain a consid-
erable proliferative potential [7]. When production of mast cells is 
required in the skin, differentiated mast cells localized in the skin 
proliferate first, and then bone marrow-derived precursors invade 
and differentiate into mast cells [8]. 
Abnormal increase of the mast cells characterizes several derma-
roses, such as urticaria pigmentosa and systemic mastocytosis. Mast 
cells release various chemical mediators, including vasoactive 
amines , eosinophil chemotactic factors, and proteolytic enzymes 
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Abbreviations: 
DMBA: 7,12-dimethylbenz( a )anthracene 
8-MOP: 8-methoxypsoralen 
GM-CSF: granulocyte-macrophage colony-stimulating factor 
HEPES: 4-(2-hydroxyethyl)-1-piperazine-ethanesulfonic acid 
IL: interleukin 
PUVA: a combinated treatment with 8-methoxypsoralen + ultravio-
let A 
PWM-SCM: pokeweed mitogen-stimulated spleen cell-conditioned 
medium 
UV: ultravio let 
UVA: long-wave ultraviolet (320- 400 nm) 
UVB: middle-wave ultraviolet (290-320 nm) 
tion chimeras, the total number of mast cells continued to 
decrease until the third week after the treatment and then 
recovered to pre-treatment levels. The initial reduction was 
attributed to the decrease of +/+-type mast cells, and the 
subsequent recovery to be as a result of the increase of bgl j 
bgl-type mast cells. This observation may explain the fact that 
the therapeutic effect ofPUVA treatment is transient. Symp-
toms of urticaria pigmentosa become manifest after the ces-
sation of PUV A treatment probably because new mast cells 
differentiate from bone marrow- derived precursors. J Invest 
Dermato/95:353-358, 1990 
[9] , and activated mast cells produce some biologically active metab-
olites of arachidonic acids [10] and cytokines, including IL-3, IL-4, 
IL-5, IL-6, and GM-CSF [11-13]. These substances may directly or 
indirectly cause itching and wealing, disabling symptoms of these 
dermatoses [14]. Beside treatments ·with antihistamines [15 , 16] or 
adrenocortical steroids [17, 18], the administration of 8-methoxy-
psoralen (8-MOP) followed by ultraviolet A (UV A) irradiation 
(PUV A treatment) has been reported to be effective in these derma-
toses [ 19- 22]. Moreover, irradiation of ultraviolet B (UVB) is also 
reported to suppress mast cell-mediated wealing [23]. 
Either PUV A treatment or UVB irradiation inhibits degranula-
tion of mast cells elicited by various chemicals such as compound 
48/80 and Concanavalin A [24- 26]. On the other hand, Briffa eta] 
[20] , Kolde et al [27], and Danno et al [26] reported that the number 
of mast cells did not change after PUV A treatment and UVB irra-
diation. Even if the total number of mast cells does not change, there 
is a possibility that the turnover of mast cells may be induced by the 
above-mentioned treatments. The mast cells that were located in 
the skin tissue before the treatments may be destroyed, and the 
decrease may be compensated by invasion and differentiation of 
bone marrow- derived precursors [28,29] . To distinguish mast cells 
localized in the skin from those newly derived from the bone 
marrow precursors, we used giant granules of mast cells from beige 
(C57BL/6-bgl jbgl, Chediak-Higashi syndrome) mice as a marker 
[8 ,30,31]. The C57BL/6-+/+ mice, which had received lethal 
irradiation and injection of bone marrow cells from C57BL/6-bgl / 
bgl donors, were used as recipients of PUV A treatment and UVB 
irradiation. Although the decrease in the total number of mast cells 
was moderate after these treatments, bgl j bgl-type mast cells in-
creased remarkably. 
MATERIALS AND METHODS 
Radiation Chimeras Mice of C57BL/6-(bgl/bgl and + / +) 
were raised in our labolatory and used at 8 weeks o( age. CSYBL/6-
+/+ mice were irradiated (8 .5 Gy) using a Tosh iba x-ray machine 
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Table I. Numbers of Mast Cells of Each Type in the Dorsal Skin of Radiation Chimeras 3 Weeks after Various Dosages ofUVB Irradiation 
Number of Mast Cells of Each Type/ mm2 (mean± SE) 
Experiment Irradiation Dose (mJ/cm2) Number of Mice +/+Type bgJ jbgJ Type Total 
0 5 
250 5 
500 5 
750 5 
2 0 5 
500 5 
• p < 0.01 , when compared to the value of nontreated control mice by Student t test. 
'p < 0.05. 
operated at 200 kV and 20 mA (target distance, 50 em; 0.7 mm 
copper+ 0.5 mm aluminum filter; 0.48 Gy/min). Bone marrow 
cells (107) obtained from C57BL/6-bgJjbgJ donors were injected 
into the retro-orbital sinus of irradiated C57BL/6-+/+ mice. The 
recipient mice were kept within a laminar-flow enclosure. Blood 
samples were obtained from the retro-orbital sinus of survivors 8 
weeks after the bone marrow transplantation. Blood smears were 
stained with Sudan Black B and counterstained with hematoxylin 
(31} . The mice that were shown to have only bgl jbgl-type granulo-
cytes were used as radiation chimeras. 
Irradiation of Ultraviolet (UV) A UV machine for dermatol-
ogy (Toshiba-Eisai M-DMR-1) was used. For UVB irradiation, five 
FL-20-SE-30 fluorescent lamps, which emitted UV of 280 to 3 70 
nm (main emission, 295 to 315 nm; peak emission, 305 nm) were 
used . The power output was 2.0 mW /cm2 at the target distance of 
40 em; the value was measured with a UV radiometer (Tokyoko-
gaku, Tokyo). For UVA irradiation, ten FL-20-BLB fluorescent 
black light lamps, which emitted UV of 300 to 357 nm (main 
emission, 347 to 357 nm; peak emission, 352 nm), were used. The 
power output was 7.0 mW jcm2 at the target distance of 15 em. 
Before UV irradiation, the hair was cut with hair clippers, and the 
mice were anesthetized with Nembutal during the irradiation. 
PUVA Treatment The original solution of 8-MOP (Taisho 
Pharmaceutical Co., Tokyo) was diluted with ethanol to 0.3% 
(final concentration, 3 mg/ml). Hairs of the dorsal skin were cut 
with hair clippers, and 0.5 ml of the diluted solution was applied 
with a blush. Mice were kept in a dark room for 1 h; their backs were 
then irradiated with UVA. 
Mast Cell Counts The mice were killed by overinhalation of 
ether. Pieces of dorsal and ventral skin were removed and fixed in 
10% formalin. Samples were embedded in paraffin and two serial 
sections (3 ;.1.1n thick) were cut from each sample. One section was 
stained with hematoxylin and eosin for histologic observation, the 
39±5 < 1 39± 5 
28± 12 7±5 36± 7 
25± 9 9 ± 1• 34± 8 
11 ± 4• 16 ± 4• 27 ± 3 
37 ±4 < 1 37 ± 4 
24 ± 3b 3 ± 1• 28 ± 3 
other with acidified toluidine blue (pH 3.0) for counting mast cells. 
The number of bgl fbgl-type and+ ;+-type mast cells were counted 
under a microscope by using a scale inserted into the eye piece. The 
number of mast cells was expressed as number per square milli-
meter. 
Clonal Cultures of Mast Cells Mice were killed by overinhala-
tion of ether. Pieces of dorsal and ventral skin were removed, 
washed in Hank's balanced salt solution buffered with HEPES (pH 
7.3) diced into fragments (s 1mm3), and incubated in Hank's solu-
tion containing collagenase (Type 1, 1.5 mg/ml, Sigma Chemical 
Co., St. Louis MO), hyaluronidase (Type 1-s, 1.5 mg/ml, Sigma), 
and 20o/o fetal bovine serum (HyClone, Logan UT) at 3rC for 2.5 
h with gentle agitation. After the incubation, the cell suspensions 
were passed through a nylon mesh and washed with a-medium 
(GIBCO, Grand Island, NY) 3 times. The number of cells was 
counted with a standard hemocytometer. Dispersed skin cells (105) 
were cultured in the methylcdlulose medium; the composition of 
the medium and culture conditions have been described by Kana-
kura eta! [33] . As a source of growth factors, pokeweed mitogen-
stimulated spleen cell-conditioned medium (PWM-SCM) was 
used . PWM-SCM was prepared according to the method described 
by Nakahara and Ogawa (34), and the content of IL-3 and IL-4 in 
PWM-SCM has been shown by Hamaguchi et al (35}. The numbers 
of mast cell colonies containing ~50 cells were counted 16 d after 
the initiation of the culture. 
Staining of Cultured Cells Individual colonies were lifted 
from the methylcellulose medium by using a 5-,ul Eppendorf pipette 
under direct microscopic visualization and collected in Eppendorf 
microcentrifuge tubes containing 0.4 ml Eagle's medium. After 
being washed twice with the medium, the samples were immedi-
ately spun in a cytocentrifuge (Cytospin 2, Shandon Southern, El-
liott, IL) at 600 rpm for 5 min. The slides were stained with May-
Gri.inwald-Giemsa solution. 
Table II. Numbers of Mast Cells of Each Type in the Dorsal Skin of Radiation Chimeras 3 Weeks after 8-MOP Administration and 
Various Dosages of UVA Irradiation 
Number of Mast Cells of Each Type/mm2 (mean± SE) 
Treatment Number 
Experiment (J/cm2) of Mice +j+ Type bglj /,gl Type Total 
None 5 37±5 < 1 37± 5 
UVA 2.5J only 5 48±9 < 1 48± 9 
8-MOP only 5 46± 5 < 1 47± 5 
8-MOP+1.5J 6 10 ± 3• 8±3• 18± _ 
8-MOP+2.5J 5 7± 3• 11 ± 3• 18 ± 3' 
8~MOP+3.5J 5 9±5• 20± 1' 28± 
2 None 5 38 ± 5 < 1 38 ± 
UVA 2.5J only 5 46± 7 < 1 47± 
8-MOP only 5 45 ± 3 < 1 46± 3 
8-MOP+2.5J 5 9 ± 1• 7±2• 16 ± 
• p < 0.01, when compared to the value of nontreated control mice by Student t test. 
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Figure 1. The skin section of a C57BL/6-+/ + mouse that had received 
X-irradiation and bone marrow transplantation from C57BL/6-bgl(bgl 
mice, 3 weeks after PUVA treatment (8-MOP administration followed by 
2.5 Jjcm2 UVA irradiation) , stained with toluidine bl ue, magnifica tion 
X400. 11, + / +-type mast cell. b, bgl ( bgl-type mast cells.+ / + -type mast cells 
have numerous small granules whereas bgl j bgl-type mast ce lls have a few 
large granules. 
RESULT S 
The backs of radiation chimeras were irradiated with various doses 
of UVB . Macroscopica lly, UVB irradiation with 250 or 500 mJ/ 
cmz resulted in erythema of the skin, and irradiation with 750 
m]fcm 2 induced ulcers. The mi ce were kill ed 3 weeks after irradia-
tion, and th e skin ti ssues were examined microscopically. 
Acanthosis of epidermis, infiltra tion of neutrophils and lympho-
cytes , and fib ros is were observed in the skin of mice irradiated with 
750 mJ /cm2 UVB. The total number of mast cells showed a rather 
moderate change. H owever, when mast cell s w ere classified into 
+ f +_ and bgl j bgl types, the former decreased and the latter increased 
sigruficantl y (Table I) . Two separate expenments were done; al-
though the decrease o f + /+-type mas t cells in 500 mJ/cm2-irra-
diated mice was significant only in experiment 2, the results of both 
experiments were consistent (Table I) . Since 750 mJ/cm2 UVB 
irradia tion appeared to cause a secondary effect th rough the develop-
ment of ulcers, we hereafter used 500 mJ/cm2 UVB irradiation. 
Administration of8-MO P was followed by various doses ofU VA 
irradiation. As macroscopic and mi croscopic alterations of the skin 
observed after 8-MOP administration and 3.5 J /cm2 U VA were 
comparable to those observed after 750 mJ/cm2 U VB irradiation, 
we selected 2. 5 J /cm2 UVA irradiation as a PUVA treatment. Al-
though neither administra tion of 8-MOP alone nor irrad iatio n of 
UV A alone induced significant change in the number of mas t cells, 
a combLnation of8-MO P and UVA resul ted in a significant decrease 
in the to tal number of mast cell s (Table II) . When the types of mast 
cells were classifi ed ,+ / +-type mas t cell s decreased and bgl f bgl-type 
mast cells increased remarkably (Fig 1, T able II). Two separate 
experime nts were done, and th e results of both experiments were 
consis tent. 
Another experiment was done to foll ow the sequential change in 
numbers of mast cells. Mice were kill ed at various times after either 
500 mJ/cm 2 UVB irradiation or PUVA treatment (UVA 2.5 J / 
cm2). As all mice received one of these treatments to the dorsal skin, 
the numbers of mas t cell s in the ventral skin were used as a control. 
For this purpose, samples were harvested from both the dorsal and 
ventral skin . In the dorsal ski n that received either UVB irradiation 
or PUV A treatment, the total number of mast cell s continued to 
decrease until th e third week after irradiation and then recovered to 
pre-irradiation levels. The initial reduction was attributed to the 
decrease of+ / +-type mast cell s, and the subsequent recovery was 
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Figure 2. The sequencia! change in the numbers of skin mast cells after 
UVB irradiation. A, dorsa l skin; B, ventral skin; opw square, to tal mas t cell s; 
ope11 circle, + j+-rype mast cell ; closed circle, bgljbgl-typc mast cell . A resul t of 
single ex periment; each point represents mean ± SE of five to eight mice. In 
tota l, 31mice were used. • p <0.05; •• p < 0.01 , when compared ro the va lue 
of nontrcated conrrol mice by Student t test. 
considered to be a result of th e increase of bgl jbgl-type mast cells 
(Figs 2 and 3). Although a statistically significa nt increase of bgl / 
bgl-type mast cells was observed in the ventral. skin 4 and 5 weeks 
after PUV A. treatment (Fig 3), the bw logtc stgmficance was not 
clear. 
Types of mast cell colony-forming cells were inves tigated 4 
weeks after U VB irradiation or PUVA trea tment. Skm-cell suspen-
sions were prepared fr.om the dorsal skin and plated in methylcellu-
lose. Each mas t-cell colony co nsis ted of either + / +-type mas t cells 
alone or bgl j bgl-type mast cells alone (Fig. 4 ). Mast cells of+ / + type 
were predominant in the skin cel l suspensiOns, but mas t cell colonies 
of bgl f bgl type were predominant in methylcellulose cultures 
(Table III) . 
DISCUSSIO N 
T he resul ts of the present study showed that the number of mas t 
cells in the skin of mice decreased after U VB irradiation and PU VA 
treatment. As compared to UVB, PUVA seemed to be more potent 
in th e abili ty to decrease mas t cell s without el iciting inflammation. 
Granerus et al (21 J reported that amelioration of symptoms such as 
itchin g and wea ling in patients with urticaria pigmentosa was ob-
served within 2 weeks after starting PUV A, and the patients were 
symptoml ess after 3-6 weeks. Such amelioration of the clinical 
symptoms after th e phototh erapy is considered to be re lated to the 
decrease in number o f skin mas t cells. O n the other hand , sequential 
exa minations of th e skin of radiation chimeras revealed that the 
number of mast cells returned to the pre-treatment level within 4 
weeks . T his observation is co nsistent with the fact that the clinical 
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Figure 3. The sequential change in the numbers of skin mast cells after 
PUVA trea tment. A, dorsal skin; B, ventral skin; ope11 square, total mast cells; 
open circle, +/+-type mast cel l; closed circle, bgJ / bgl-cype mast cel l. A result of 
single experiment; each point represents mean± SE of five to nine mice. In 
total, 35 mice were used.* p < 0.05; ** p < 0 .01, when compared to the value 
of non-treated control mice by Student t test. 
effects of phototherapy are transient and symptoms become mani-
fest after the cessation of the therapy (20) . 
In the prese nt study, we differentiated mast cells that were local-
ized in the skin ti ssue from mast cells that were newly derived from 
the bone marrow by using giant granules of mast cells from beige 
mice. Because we identified mast cells by staining with toluidine 
blue, the possibility that the initial decrease of mast cells is due to the 
loss of stainability of the granules cannot be excluded. However, 
bgJ/bgl-type but not +/+-type mast cell s increased after the initial 
decrease, and we consider that the decrease represents the loss of 
skin-localized mast cells induced by UVB irradiation or by PUV A 
trea tment, and that the recovery is attributed to the invasion and 
differentiation of bone marrow-derived precursors. This is consist-
ent with the result of Sonoda et al [8), who described a comparable 
change after painting, 7, 12-dimethylbenz (a) anthracene (DMBA) 
onto the dorsa l skin of radiation chimeras. Kanakura et al (36) and 
Waki et al (37) recently demonstrated that the presence of differen-
tiated mast cells inhibited both the invasion of mast-cell precursors 
into the peritoneal cavity and the differentiation of these precursors 
into mast cells. The presence of+ /+-type skin mas t cells probably 
suppressed th e invasion of bgJ j bgl-type precursors into the skin. The 
loss of+ j+ mast cells that resulted from UVB irradiation, PUV A 
treatment, or DMBA administration may induce the invasion of 
b,~J jbgl-type mast-cel l precursors and their differentiation into mor-
phologically identifiable mast cells. Hyperplasia of epidermis and 
remarkable infiltration of inflammatory cells were observed after 
the administration of DMBA, whereas a minimal erythema dose of 
UVB irradiation or mjnimal phototoxic dose ofPUVA treatment is 
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Figure 4. A, a medium-siz~ 
mast cell colony mast cell colon)' 
observed on day 16 after initiation 
of cu lture, magnification X200; B, 
+/+-type m~st cells, stained '"!th 
May Gri.inwald-Giemsa, magnifi-
cation X400; C, bgJjbgJ-cype mas 
cells, stained with May-G fiin. 
wald-Giemsa, magnification 
X400. 
enough to induce a significant decrease of skin localized mast cell 
Therefore, UVB irrad iation and PUV A trea tment are more suitable 
than DMBA administration as an experimental procedure to induct 
the turnover of mast cells. 
When skin cells of radiation chimeras that had received UVB 
irradiation or PUV A treatment were cultured in methylcellulose, 
m.ast cel l co lonies of both+/+ and bgJjbgJ types developed (Tablt 
III) . This indicates that mast cell colony-forming cells of + /+ ori· 
gin survived after these treatments, and suggested that mast c~l 
damage induced by these treatments may be compensated by prohl-
eration of mast cell precursors existing in the skin in addition 
supply from the bone marrow. H owever, w hen the proportion ' 
morphologically identifiable+ /+-type mast cells was compared 
th at of +/+-type mast cell colony-forming cells in the skin which 
received UVB irradiation or PUV A treatment, the former was sig-
nificantly larger than the latter (Table lll). Although the morphol-
ogy of mast cel l colony-forming cells localized in the skin has n 
been determined, Kanakura et al (33] suggested that some morpho-
logically identifiable skin mast cells th emselves may form mast c 
colonies in methylcellulose. In fact, about 30% of morphologically 
identifiable mast cell s in the peritoneal cavity produce mast cefi 
colonies [34]. Some explanations are possibl e for the results show 
in Table lll. Skin mast cells w ith colony-forming potential may ~ 
more sensitive to UVB irradiation or PUV A treatment than skin 
mast cells without colony-forming potential. Thus, after UVB im-. 
diation or PUV A trea tment,+ / +-type cells were remarkable wh 
the skin cells were investigated morphologically, but bgJ jbgl-typ..• 
colonies were apparently predominant when the skin cells w ert 
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Table III. Proportion of Morphologically Identifiable Mast 
Ce lls and Mast Cell Colony-Forming Cells of Each Type 4 
Weeks After UVB Irradiation or PUV A Treatment 
Treatment 
UVB 
irradiation 
PUVA 
treatment 
Cells 
Mast ce ll• 
Mast ce ll 
colony-
forming cell• 
Mast cellb 
Mast ce ll 
colony-
forming cellb 
Proportion of 
Cells of Each 
T ype(%)' 
+ / +Type bgl j bgl Type 
85 15 
21 79 
56 44 
17 83 
• Skin cel l suspensions of six radiation chimeras were pooled and plated in methylccl-
lulose; 500 mast cell s and 155 mast-cell colonies were class ified. 
• Skin cell suspensions of six radiation chimeras were pooled and plated in methylccl -
lulose; 400 mast cells and 207 mast-cell colonies were classified. 
' The proportion of+ / +-type (or bgl jbs_l-type) mast ce lls were significantly different 
from the population of +/+-type (or bglj bgl-type) mast cell colony-forming cells after 
either UVB irradiation or PUVA treatment (p < 0.01, when compared by X2 test). 
cultured in methylcellulose . Some + / +-type mast cell s with col-
ony- fo rming potential, which survived the UVB irradiation or the 
PUV A treatment, m ay lose colony-forming potential after divisions 
induced by loss of neighboring m as t cells. 
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